Quick Answer
JRSIS HEALTH CARE Corp reported Total Revenue of $3.46 million for fiscal year 2023.
JRSIS HEALTH CARE Corp — Key Financials by Year
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Total Revenue | $3.46M +101.4% |
$1.72M -96.1% |
$44.39M +24.3% |
$35.71M | — | — |
| Net Income | -$80.9K +85.9% |
-$575.8K -118.1% |
$3.19M -16.7% |
$3.83M +331.0% |
$888.1K -55.4% |
$1.99M -57.1% |
| Diluted EPS | -$0.00 +88.9% |
-$0.01 -105.3% |
$0.17 +16.6% |
$0.15 +177.1% |
$0.05 -60.3% |
$0.13 |
| Total Assets | $2.14M +5.1% |
$2.04M -97.3% |
$75.69M +28.7% |
$58.80M +13.9% |
$51.63M -1.6% |
$52.47M +7.8% |
| Cash and Equivalents | — | $58.6K +96.4% |
$29.8K -96.5% |
$844.8K -57.1% |
$1.97M +668.6% |
$256.4K -71.0% |
| Stockholders Equity | -$137.4K -135.1% |
-$58.5K -100.3% |
$22.07M +15.9% |
$19.04M +28.5% |
$14.82M +4.8% |
$14.14M +9.6% |
| R&D Expense | $189.3K -33.1% |
$283.0K | — | — | — | — |
| Operating Income | -$188.6K +72.5% |
-$684.8K -559.7% |
-$103.8K -101.9% |
$5.59M +19.8% |
$4.67M -22.1% |
$5.99M -10.0% |
| Gross Profit | $483.1K +1742.9% |
$26.2K | — | — | — | — |
| Shares Outstanding | 82.59M +7.6% |
76.76M +312.0% |
18.63M +2.1% |
18.25M +1.5% |
17.98M +20.0% |
14.97M +0.9% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2024 | $222.9K | -55.2% | -62.7% |
| Net Income | September 30, 2024 | -$188.1K | -658.2% | -83.7% |
| Diluted EPS | September 30, 2024 | -$0.00 | -650.0% | -120.0% |
| Total Assets | September 30, 2024 | $2.07M | +267.1% | -1.9% |
| Cash and Equivalents | September 30, 2023 | $33.4K | +201.2% | +18.3% |
| Long-Term Debt | September 30, 2024 | $6.3K | — | -48.2% |
| Stockholders Equity | September 30, 2024 | -$197.6K | -141.7% | -2569.8% |
| R&D Expense | September 30, 2024 | $28.8K | -20.3% | +200.4% |
| Operating Income | September 30, 2024 | -$206.2K | -504.2% | -73.7% |
| Gross Profit | September 30, 2024 | $26.9K | -77.6% | -85.6% |
| Shares Outstanding | September 30, 2024 | 84.60M | +1349.4% | +0.0% |
- JRSIS HEALTH CARE Corp reported Total Revenue of $3.46 million for fiscal year 2023.
- JRSIS HEALTH CARE Corp showed an increase of +101.4% in Total Revenue compared to the prior fiscal year.
- JRSIS HEALTH CARE Corp reported Net Income of -$80.9 thousand for fiscal year 2023.
- JRSIS HEALTH CARE Corp showed an increase of +85.9% in Net Income compared to the prior fiscal year.
- JRSIS HEALTH CARE Corp reported Diluted EPS of $0.00 per share (loss) for fiscal year 2023.
- JRSIS HEALTH CARE Corp showed an increase of +88.9% in Diluted EPS compared to the prior fiscal year.
- JRSIS HEALTH CARE Corp reported Total Assets of $2.14 million for fiscal year 2023.
- JRSIS HEALTH CARE Corp showed an increase of +5.1% in Total Assets compared to the prior fiscal year.
- JRSIS HEALTH CARE Corp reported Cash and Equivalents of $58.6 thousand for fiscal year 2022.
- JRSIS HEALTH CARE Corp showed an increase of +96.4% in Cash and Equivalents compared to the prior fiscal year.
- JRSIS HEALTH CARE Corp reported Stockholders Equity of -$137.4 thousand for fiscal year 2023.
- JRSIS HEALTH CARE Corp showed a decrease of -135.1% in Stockholders Equity compared to the prior fiscal year.
- JRSIS HEALTH CARE Corp reported R&D Expense of $189.3 thousand for fiscal year 2023.
- JRSIS HEALTH CARE Corp showed a decrease of -33.1% in R&D Expense compared to the prior fiscal year.
- JRSIS HEALTH CARE Corp reported Operating Income of -$188.6 thousand for fiscal year 2023.
- JRSIS HEALTH CARE Corp showed an increase of +72.5% in Operating Income compared to the prior fiscal year.
- JRSIS HEALTH CARE Corp reported Gross Profit of $483.1 thousand for fiscal year 2023.
- JRSIS HEALTH CARE Corp showed an increase of +1742.9% in Gross Profit compared to the prior fiscal year.
- JRSIS HEALTH CARE Corp reported Shares Outstanding of 82.59 million shares for fiscal year 2023.
- JRSIS HEALTH CARE Corp showed an increase of +7.6% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: